TY  - GEN
AU  - Baragi,Vijaykumar M
AU  - Becher,Gabriel
AU  - Bendele,Alison M
AU  - Biesinger,Ralf
AU  - Bluhm,Harald
AU  - Boer,Jürgen
AU  - Deng,Hongbo
AU  - Dodd,Rory
AU  - Essers,Michael
AU  - Feuerstein,Tim
AU  - Gallagher,Brian M
AU  - Gege,Christian
AU  - Hochgürtel,Matthias
AU  - Hofmann,Michael
AU  - Jaworski,Andreas
AU  - Jin,Lixia
AU  - Kiely,Andrew
AU  - Korniski,Brian
AU  - Kroth,Heiko
AU  - Nix,Darrell
AU  - Nolte,Bert
AU  - Piecha,Dorothea
AU  - Powers,Timothy S
AU  - Richter,Frank
AU  - Schneider,Matthias
AU  - Steeneck,Christoph
AU  - Sucholeiki,Irving
AU  - Taveras,Arthur
AU  - Timmermann,Andreas
AU  - Van Veldhuizen,Joshua
AU  - Weik,Juergen
AU  - Wu,Xinyuan
AU  - Xia,Bing
TI  - A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models
SN  - 0004-3591
PY  - 2009///0914
KW  - Animals
KW  - Cartilage, Articular
KW  - drug effects
KW  - Cattle
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Enzyme Inhibitors
KW  - pharmacology
KW  - Humans
KW  - Interleukin-1alpha
KW  - Iodoacetates
KW  - Iodoacetic Acid
KW  - adverse effects
KW  - Male
KW  - Matrix Metalloproteinase Inhibitors
KW  - Musculoskeletal System
KW  - Oncostatin M
KW  - Osteoarthritis
KW  - chemically induced
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/art.24629
ER  -